Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SMESTAD APOTEK AS
AS
Active
Org 997893492
Sørkedalsveien 90A, 0377 Oslo
Retail sale of pharmaceutical products · NACE 4773
Est. 2012
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 14M
+20% vs 2023
EBITDA margin
4.9%
+116% vs 2023
Equity ratio
48.6%
Financial strength
Net profit 2024
NOK 510K
+117% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
0M
-100%
2022
0M
0%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 14M
+20%
EBITDA
NOK 682K
+116%
Net profit
NOK 510K
+117%
Total assets
NOK 4M
+30%
Equity
NOK 1,9M
+36%
Employees
5
—
Company information
Legal name
SMESTAD APOTEK AS
Org number
997893492
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
28. januar 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av apotekvarer.
Contact
Address
Sørkedalsveien 90A, 0377 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
4M
8M
12M
16M
10M
2020
11M
2021
12M
2022
12M
2023
14M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
10 027
11 319
11 567
11 738
14 037
Staff expenses
−886
−1 177
−1 317
−1 478
−1 406
EBITDA
918
607
343
316
682
Depreciation & amort.
−56
−43
−21
−12
−21
EBIT
863
564
322
303
661
Net financials
−0
−0
−0
3
0
Profit before tax
862
564
322
306
661
Tax
190
126
75
72
152
Net profit
672
438
247
235
510
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 018
2 737
2 753
3 068
3 995
Equity
661
1 100
1 347
1 432
1 942
Long-term debt
0
6
0
0
0
Short-term debt
1 357
1 631
1 406
1 636
2 053
Total debt
1 357
1 637
1 406
1 636
2 053
Financial ratios
5-year trend
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
2020
2024
Equity ratio
48.6%
This company
38.2%
Market median
+27% vs market
2020
2024
Return on equity
26.3%
This company
18.4%
Market median
+43% vs market
2020
2024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
2020
2024
Asset turnover
3.51×
This company
1.12×
Market median
+213% vs market
2020
2024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
BA
Basel Adi
Chief Executive Officer
Chief Executive Officer
2012
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MA
Maher Adi
Board of Directors
2012
KR
Kathrina Ramberg
Board of Directors
2012
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Adi Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Adi Holding As
SMESTAD APOTEK AS
(this company)
Board network connections
Board members of SMESTAD APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Basel Adi
Chief Executive Officer
0 companies
Maher Adi
Board of Directors
0 companies
Kathrina Ramberg
Board of Directors
0 companies